Reaction
Cancer Fatigue reporting signals
As of the last recalculation, Cancer Fatigue appears in 224 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is BRENTUXIMAB VEDOTIN (PRR 156.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Brentuximab Vedotin | 16 | 156.1 | 156.4 |
| Mesna Injection | 12 | 142.5 | 142.7 |
| Mesna | 12 | 139.9 | 140.1 |
| Pemetrexed | 10 | 45.3 | 45.3 |